DB Fitzpatrick & Co’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
DB Fitzpatrick & Co's AMGN Position: Q2 2026 in Review
DB Fitzpatrick & Co reduced its Amgen (AMGN) stake by 1.2% in Q2 2026, selling an estimated $16.1K and leaving 3,755 shares worth $1.36M. The position accounts for 1.1% of the portfolio, ranked #31.
DB Fitzpatrick & Co first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.38M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- DB Fitzpatrick & Co held 3,755 shares of Amgen worth $1.36M as of Q2 2026.
- DB Fitzpatrick & Co sold 47 Amgen shares in Q2 2026, an estimated $16.1K.
- Amgen made up 1.1% of DB Fitzpatrick & Co's portfolio in Q2 2026, its #31 holding.
- DB Fitzpatrick & Co first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
- DB Fitzpatrick & Co's Amgen position peaked at $1.38M in Q3 2024.
- 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on DB Fitzpatrick & Co's 13F filing for Q2 2026, filed 15 Jul 2026.